Vimian Group AB (publ) (OTCMKTS:VIMGF) Short Interest Update

Vimian Group AB (publ) (OTCMKTS:VIMGF) was the target of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 174,400 shares, an increase of 122.2% from the February 13th total of 78,500 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Vimian Group AB (publ) Price Performance

Shares of VIMGF opened at C$3.50 on Friday. Vimian Group AB has a 1 year low of C$2.68 and a 1 year high of C$4.12. The company’s fifty day moving average is C$3.50 and its two-hundred day moving average is C$3.71.

Vimian Group AB (publ) Company Profile

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.